is associated with reticulocytopenia and the absence of erythroid precursors in the bone marrow
seen in 1% to 6% of patients
therapy related autoimmunity
alkylating agents, radiotherapy, and purine analogues may be responsible
infections
according to the estimates, up to 70% of patients will develop infections
second malignancies
Kaposi sarcoma, malignant melanoma, cancers of the larynx and lung, brain cancer, and cancers of the stomach and bladder are seen in up to 11% of CLL patients
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.